• We are a biotech company in
    infectious diseases with
    two marketed products.

  • Dedicated to innovation in
    vaccine research & development.

  • Valneva covers the full
    value chain from bench
    to market.


Welcome to Valneva

A leading pure play vaccine biotech company.


— August 31, 2015

Valneva Presents its H1 2015 Results and Provides Business Update

Read more

— Stock information



—News, July 23, 2015

Valneva and PaxVax Enter into Marketing and Distribution Agreement

 Read more

— Financial calendar

November 10, 2015  
Q3 Results 2015

All dates       


play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

– Upcoming conferences and fairs

Munich, Germany
2–4 November, 2015 

World Vaccine Congress Europe
Madrid, Spain
9-11 November 2015

Jefferies Autumn 2015 Global Healthcare Conference London, UK
18-19 November, 2015


European pure vaccine player with international footprint.

Please update your browser...